Kaan Helvacı
3PUBLICATIONS
13CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Jan 10, 2026
Durvalumab-Based First-Line Chemoimmunotherapy in Advanced Biliary Tract Cancer: Real-World Outcomes and Prognostic Factors-A Turkish Oncology Group Study.Safa Can Efil, Fatih Kus, Bahadir Koylu
|May 14, 2025
The Clinical Outcomes and Safety of Sacituzumab Govitecan in Heavily Pretreated Metastatic Triple-Negative and HR+/HER2- Breast Cancer: A Multicenter Observational Study from Turkey.Harun Muğlu, Kaan Helvacı, Bahadır Köylü
|Jan 25, 2025
Endocrine Adverse Events in Patients Treated with Immune Checkpoint Inhibitors: A Comprehensive Analysis.Meriç Dökmetaş, Harun Muğlu, Erkan Özcan
Pageof 1
Frequent Collaborators
2 joint publications
Bahadır Köylü
2 joint publications
Harun Muglu
1 joint publications
Safa Can Efil
1 joint publications
Banu Ozturk
1 joint publications
Ozkan Alan
1 joint publications
Sedat Biter
1 joint publications
Ferit Aslan
1 joint publications
Sinem Akbas
1 joint publications
Buket Bayram Kuvvet
1 joint publications
Mehmet Haluk Yücel
